DIRS.INFO The most relevant business & tech news

☆ Microsoft says it will sell Activision streaming rights to Ubisoft to unblock its takeover bid
▼ + stars: | 2023-08-22 | by ( Pete Syme | ) www.businessinsider.com time to read: +3 min

Microsoft has restructured its deal to hand Activision cloud gaming rights to rival Ubisoft. Microsoft really wants to get its takeover of Activision Blizzard over the line. The tech giant has substantially restructured its deal to try and appease the UK regulator's concerns that a takeover would hurt competition in cloud gaming. The new deal involves selling Activision cloud-gaming rights for countries outside the European Economic Area to video-game publisher Ubisoft. Microsoft announced its intent to acquire Activision Blizzard for $68.7 billion in January 2022, but the deal has been entangled in competition concerns ever since.

Persons: Sarah Cardell, Brad Smith Organizations: Microsoft, Activision, Ubisoft, Morning, Activision Blizzard, Economic Area, Cloud Gaming, European Commission, Markets Authority, CMA Locations: British

☆ Microsoft submits new Activision Blizzard takeover deal to British regulator after initial block
▼ + stars: | 2023-08-22 | by ( Arjun Kharpal | ) www.cnbc.com time to read: +3 min

Dado Ruvic | ReutersMicrosoft on Tuesday submitted a new deal for the takeover of Activision Blizzard, offering a spate of concessions after U.K. regulators rejected its initial proposal. Under the restructured deal, Microsoft will not acquire cloud rights for existing Activision PC and console games, or for new games released by Activision during the next 15 years, the CMA said. Regulators previously argued that Microsoft could also take key Activision games, like Call of Duty, and make them exclusive to Xbox and other Microsoft platforms. To cross that line, Microsoft offered concessions, such as offering royalty-free licenses to cloud gaming platforms to stream Activision games, if a consumer has purchased them. In the U.S., the Federal Trade Commission was fighting a legal battle with Microsoft in an effort to get the Activision takeover scrapped.

Persons: Dado Ruvic, Brad Smith Organizations: Activision, Reuters Microsoft, Activision Blizzard, Markets Authority, Microsoft, CMA, Redmond, Activision PC, Ubisoft Entertainment, Ubisoft, Netflix, European Union, Federal Trade Commission Locations: U.S, Europe

☆ FAA issues requirement for GTF engine inspections to address high pressure turbine disk issue
▼ + stars: | 2023-08-18 | by ( ) www.reuters.com time to read: +1 min

Pratt & Whitney logo is pictured on the GTF engine at the 54th International Paris Air Show at Le Bourget Airport near Paris, France, June 20, 2023. REUTERS/Benoit Tessier Acquire Licensing RightsAug 18 (Reuters) - The Federal Aviation Administration will require some users of Pratt & Whitney's <RTX.> geared turbofan engine to conduct ultrasonic inspections of a key part within 30 days, the agency said in an airworthiniess directive published Friday. The new airworthiness directive codifies the regulator's response to the previously disclosed problem. RTX declined to comment on the directive. Reporting by Valerie InsinnaOur Standards: The Thomson Reuters Trust Principles.

Persons: Pratt, Whitney, Benoit Tessier, Pratt & Whitney, Valerie Insinna Organizations: International Paris Air, Le, REUTERS, Federal Aviation Administration, Pratt, Pratt &, RTX Corp, Airbus, Thomson Locations: Le Bourget, Paris, France

☆ US FDA approves Regeneron's ultra-rare blood disease drug
▼ + stars: | 2023-08-18 | by ( Pratik Jain | ) www.reuters.com time to read: +2 min

REUTERS/Brendan McDermid/File Photo Acquire Licensing RightsAug 18 (Reuters) - Regeneron Pharmaceuticals (REGN.O) said on Friday the U.S. health regulator approved its drug to treat a rare blood disease. The drug pozelimab, branded as Veopoz, would treat CHAPLE disease in adult and pediatric patients 1 year of age and older. Regeneron said the disease has fewer than 10 patients identified in the U.S. and estimates less than 100 patients worldwide. With Veopoz's approval, the company said the pre-approval inspection issues related to the marketing application of the higher dose of its blockbuster eye disease drug Eylea, or aflibercept, has been addressed. The FDA had in June declined to approve the higher-dose version following an inspection at third-party manufacturer Catalent (CTLT.N).

Persons: Brendan McDermid, Veopoz, Regeneron, 8mg, Evan Seigerman, Seigerman, Vaibhav Sadhamta, Khushi, Shilpi Majumdar Organizations: Regeneron Pharmaceuticals, REUTERS, U.S . Food, Drug Administration, Reuters, BMO Capital, FDA, Thomson Locations: Westchester, Tarrytown , New York, U.S, Bengaluru

☆ Binance files for protective order against SEC
▼ + stars: | 2023-08-15 | by ( ) www.reuters.com time to read: +1 min

REUTERS/Dado Ruvic/Illustration/File PhotoAug 15 (Reuters) - Crypto exchange Binance late on Monday filed for a protective court order against the U.S. Securities and Exchange Commission saying the regulator's requests for information were "over broad" and "unduly burdensome". In a court filing in the US District Court of Columbia, BAM Trading, Binance U.S.'s operating company and BAM Management said the group had already provided sufficient information to the regulator. The protective order seeks to limit the SEC, among other things, to four depositions from BAM employees, and to drop the deposition of BAM's chief executive and of its chief financial officer, without naming anyone. Binance and the SEC did not immediately respond to a request for comment. The SEC has declined BAM's proposals to meaningfully limit its requests and is opposed to the motion for a protective order, the filing said.

Persons: Dado Ruvic, Changpeng Zhao, Lavanya, Kim Coghill, Sharon Singleton Organizations: REUTERS, U.S . Securities, Exchange Commission, Court, Columbia, BAM, BAM Management, SEC, Thomson Locations: U.S, Bengaluru

☆ US FDA approves Pfizer's blood cancer therapy
▼ + stars: | 2023-08-14 | by ( ) www.reuters.com time to read: +2 min

REUTERS/Johanna Geron/File PhotoAug 14 (Reuters) - The U.S. Food and Drug Administration on Monday granted accelerated approval to Pfizer's (PFE.N) therapy for treating patients with a type of blood cancer that is difficult to treat, the company said. Multiple myeloma is a common type of blood cancer, which develops in the bone marrow and can spread throughout the body. The FDA approval is based on data from a mid-stage study that showed that 58% of patients treated with Pfizer's therapy had no signs of cancer or had seen a significant decrease in cancer cells in the body. Pfizer said it will continue testing the therapy in ongoing late-stage trials to expand its use in earlier lines of treatment for patients. The therapy's approval comes with a boxed warning for neurologic toxicity and cytokine release syndrome, a condition where the immune system reacts more aggressively.

Persons: Johanna Geron, Epkinly, Johnson, Pfizer's, Bhanvi Satija, Leroy Leo, Pratik, Shounak Dasgupta Organizations: Pfizer, REUTERS, U.S . Food, Drug Administration, FDA, Thomson Locations: Puurs, Belgium, U.S, Bengaluru

☆ Aussie telecom firms Telstra, TPG will not appeal block of asset transfer deal
▼ + stars: | 2023-08-13 | by ( ) www.reuters.com time to read: +1 min

REUTERS/David Gray/Aug 14 (Reuters) - Australian telecom firms Telstra Group (TLS.AX) and TPG Telecom (TPG.AX) on Monday said separately they would not appeal the country's competition tribunal's decision to block an asset transfer deal between the two telecom giants. In June, the Australian Competition Tribunal upheld the competition regulator's decision to block the deal between the telecom firms, under which Telstra would have bought spectrum and transmission towers from TPG, while TPG would have kept selling 4G and 5G coverage using Telstra infrastructure. The country's competition regulator had ruled against the asset transfer deal in December citing competition concerns and potentially impacting the no. Telstra did not provide any details about its decision to not appeal the tribunal's decision in the exchange filing, and did not immediately respond to a Reuters request for further details. TPG Telecom, which also did not provide any reason, said it would "continue to explore commercial options to expand its mobile network".

Persons: David Gray, Sameer Manekar, Diane Craft Organizations: Telstra, REUTERS, Australian, Telstra Group, TPG Telecom, TPG, Optus, Singapore Telecommunications, Thomson Locations: Sydney, Australia, Bengaluru

REUTERS/Gonzalo Fuentes/File PhotoOSLO, Aug 8 (Reuters) - Meta Platforms (META.O) is asking a court in Norway to stop a fine the Nordic country's data regulator imposed on the owner of Facebook and Instagram for breaching users' privacy, according to a court filing. Meta Platforms will be fined 1 million crowns ($97,700) per day from Aug. 14 over privacy breaches, Norway's data protection authority told Reuters on Monday, in a decision that could have wider European implications. Meta Platforms is asking for a temporary injunction against the order, according to a court filing. Meta Platforms did not reply to a request for comment. The Norwegian data regulator, Datatilsynet, said Meta Platforms was seeking to stop the imposition of the fine.

Persons: Gonzalo Fuentes, Tobias Judin, Datatilsynet, Gwladys Fouche, Kirsten Donovan Organizations: Viva Technology, Porte de, REUTERS, Facebook, Reuters, Big Tech, European Data Protection, Thomson Locations: Porte, Paris, France, OSLO, Norway, Norwegian, Europe, Oslo

The logo of Meta Platforms' business group is seen in Brussels, Belgium December 6, 2022. REUTERS/Yves Herman/File Photo/File PhotoOSLO, Aug 7 (Reuters) - Facebook and Instagram owner Meta Platforms (META.O) will be fined 1 million Norwegian crowns ($98,500) per day over privacy breaches from Aug. 14, Norway's data protection authority told Reuters on Monday. The regulator, Datatilsynet, had said on July 17 that the company would be fined if it did not address privacy breaches the regulator had identified. Meta Platforms did not immediately reply to a request for comment. Norway is not a member of the European Union but is part of the European single market.

Persons: Yves Herman, Datatilsynet, Tobias Judin, Meta, Meta's, Gwladys Fouche, Terje Solsvik, David Gregorio Our Organizations: REUTERS, Meta, Reuters, Big Tech, European Data Protection, European Union, Facebook, Ireland's Data, European, Thomson Locations: Brussels, Belgium, OSLO, Norway, Norwegian, Europe, Oslo

REUTERS/Andrew Kelly/File PhotoAug 7 (Reuters) - The U.S. drug regulator's approval of Biogen (BIIB.O) and Sage Therapeutics' (SAGE.O) first-of-its-kind postpartum depression (PPD) pill is unlikely to allay the drugmakers' growth concerns, analysts said on Monday. Adverse commentary after their PPD drug was approved by the U.S. Food and Drug Administration (FDA) on Friday sent Sage shares tumbling 40%, while Biogen dropped 3% in premarket trading. Zurzuvae's use as a clinical depression treatment represents a more than $1 billion sales opportunity compared with $250 million to $500 million potential for postpartum depression, said Jefferies analyst Michael Yee. "Postpartum depression is not necessarily where a big commercial opportunity is," Biogen CEO Christopher Viehbacher said last month. The U.S. FDA said last week that additional studies might be required to support the drug's approval for major depressive disorder (MDD), or clinical depression.

Persons: Andrew Kelly, Sage, Biogen, Baird, Brian Skorney, Skorney, Zurzuvae, Jefferies, Michael Yee, Christopher Viehbacher, Yee, Mariam Sunny, Bhanvi, Manas Mishra, Vinay Dwivedi Organizations: Food and Drug Administration, FDA, REUTERS, Sage Therapeutics, U.S . Food, Drug Administration, U.S, Thomson Locations: White Oak , Maryland, U.S, Bengaluru

A representation of the cryptocurrency is seen in front of Coinbase logo in this illustration taken, March 4, 2022. REUTERS/Dado Ruvic/Illustration/File PhotoNEW YORK, Aug 4 (Reuters) - Coinbase Global (COIN.O) on Friday asked a judge to end the U.S. Securities and Exchange Commission's lawsuit accusing the world's largest publicly traded cryptocurrency exchange of violating federal securities laws. Coinbase was sued by the SEC in June, and accused of operating illegally as a national securities exchange, broker and clearing agency without registering with the regulator. Firms are closely watching the litigation between the SEC and Coinbase, with some onlookers deeming it an "existential" clash. Coinbase leaned on the recent Ripple matter in Friday's filing, noting the SEC's lawsuit hinges on the type of transactions that the judge deemed outside of the regulator's jurisdiction.

Persons: Dado Ruvic, Coinbase, Paul Grewal, Chris Prentice, Toby Chopra, Jonathan Oatis Organizations: REUTERS, U.S . Securities, Exchange, SEC, Labs, Thomson Locations: Manhattan

☆ UK markets watchdog ready to pounce as new consumer power comes into force
▼ + stars: | 2023-07-31 | by ( Huw Jones | ) www.reuters.com time to read: +3 min

The new duty is particularly significant for being more granular, requiring "good outcomes" and no "forseeable harm" for customers across products and services, price and value. The duty will help the FCA tackle harms pre-emptively to stop a mis-selling scandal in the first place, she added. Firms will have to demonstrate to the FCA how they are providing good outcomes, a step the watchdog hopes will improve on the low trust in financial services. It says it will help ensure that banks pass on higher interest rates to savers, and provide help to those struggling to pay a mortgage. ($1 = 0.7770 pounds)Reporting by Huw Jones; Editing by Conor HumphriesOur Standards: The Thomson Reuters Trust Principles.

Persons: Nisha Arora, Arora, Philip Deeks, James's, Jonathan Herbst, Herbst, KPMG's Deeks, Deeks, Huw Jones, Conor Humphries Organizations: Financial, Authority, FCA, Reuters, Norton Rose, Thomson

The Texas Bankers Association (TBA), American Bankers Association (ABA) and a small Texas bank sued in April, saying the CFPB had no authority to issue the rule because an appeals court found the regulator's funding structure unlawful. U.S. District Court Judge Randy Crane in McAllen, Texas, granted a preliminary injunction blocking the CFPB from enforcing the rule against members of both groups and McAllen-based Rio Bank. Crane blocked the rule pending a ruling by the U.S. Supreme Court on the CFPB's funding structure. The law also required the small business loan rule. 23-00144, U.S. District Court, Southern District of Texas.

Persons: Randy Crane, Crane, Dodd, Frank, Jody Godoy, Nick Zieminski Organizations: Consumer Financial Protection Bureau, Supreme, Texas Bankers Association, American Bankers Association, ABA, U.S, Rio Bank, Circuit, Appeals, Federal Reserve, Congress, U.S . Constitution, Consumer Financial, Court, Southern District of Texas, Thomson Locations: Texas, U.S, McAllen , Texas, McAllen, U.S ., Southern District, New York

LONDON, July 31 (Reuters) - A German data watchdog has been investigating OpenAI CEO Sam Altman's Worldcoin project since late last year due to concerns over its large-scale processing of sensitive biometric data, the regulator's president told Reuters. Will said the Bavarian state regulator is the lead authority investigating Worldcoin under the European Union's data protection rules because Tools For Humanity, the company behind Worldcoin, has a German subsidiary there. This leads to a number of risks, including whether users have given explicit consent to their highly-sensitive biometric data being processed on the basis of "sufficient and clear" information, Will said. Privacy campaigners have long raised concerns about the wide-scale collection and storage of biometric data, which could increase surveillance or target certain demographic groups. France's privacy watchdog told Reuters on Friday that the legality of Worldcoin's data collection "seems questionable".

Persons: Sam Altman's Worldcoin, Worldcoin, Michael Will, Will, Elizabeth Howcroft, Louise Heavens Organizations: Reuters, Bavarian State Office, Data Protection, Humanity, Worldcoin, Thomson Locations: Bavarian, German, Cayman Islands, France, Germany, Spain

☆ US FDA approves second over-the-counter opioid overdose reversal drug
▼ + stars: | 2023-07-28 | by ( ) www.reuters.com time to read: +1 min

July 28 (Reuters) - The U.S. Food and Drug Administration has approved the prescription-free sale of the second opioid overdose reversal drug, its manufacturer Harm Reduction Therapeutics said on Friday. The approval of the drug, called RiVive, will provide patients with another over-the-counter option in the United States, where drug-related overdose deaths surpassed 100,000 in 2021. Harm Reduction said it anticipates that RiVive will be available early next year, primarily to harm-reduction organizations and state governments. Harm Reduction Therapeutics has partnered with contract drug manufacturer Catalent Inc (CTLT.N) to manufacture RiVive. Reporting by Sriparna Roy and Bhanvi Satija in Bengaluru; Editing by Pooja DesaiOur Standards: The Thomson Reuters Trust Principles.

Persons: drugmaker, Michael Hufford, Sriparna Roy, Bhanvi, Pooja Desai Organizations: U.S . Food, Drug Administration, Therapeutics, Harm, Catalent Inc, Thomson Locations: U.S, United States, Bengaluru

☆ U.S. FDA approves second over-the-counter opioid overdose reversal drug
▼ + stars: | 2023-07-28 | by ( ) www.cnbc.com time to read: +1 min

Naloxone, packaged with instructions, is one of the items given out by the Baltimore Harm Reduction Coalition outreach workers. The U.S. Food and Drug Administration has approved the prescription-free sale of the second opioid overdose reversal drug, its manufacturer Harm Reduction Therapeutics said on Friday. The approval of the drug, called RiVive, will provide patients with another over-the-counter option in the United States, where drug-related overdose deaths surpassed 100,000 in 2021. Harm Reduction said it anticipates that RiVive will be available early next year, primarily to harm-reduction organizations and state governments. Harm Reduction Therapeutics has partnered with contract drug manufacturer Catalent Inc to manufacture RiVive.

Persons: drugmaker, Michael Hufford, BioSolutions Organizations: Reduction Coalition, U.S . Food, Drug Administration, Therapeutics, Harm, Catalent Inc Locations: Baltimore, U.S, United States

☆ FDIC launches sale of $18.5 billion of Signature Bank loans
▼ + stars: | 2023-07-28 | by ( ) www.reuters.com time to read: +1 min

July 28 (Reuters) - The U.S. Federal Deposit Insurance Corporation (FDIC) set in motion the sale of an $18.5 billion loan portfolio from Signature Bank this week, a set of loans linked to major private equity and investing firms, according to the regulator's website. The FDIC hired Newmark Group (NMRK.O) in March to sell about $60 billion of Signature Bank's loans, after state regulators decided to close down the failed lender amid a turmoil in regional banks earlier this year. The sale was launched on July 25 and is limited to FDIC-insured depository institutions, the Bloomberg report said. The notice reads that the loans for sale "consist of subscription credit facilities to private equity funds." Reporting by Pritam Biswas in Bengaluru; Editing by Arun KoyyurOur Standards: The Thomson Reuters Trust Principles.

Persons: Thoma, Newmark, Pritam Biswas, Arun Koyyur Organizations: U.S, Federal Deposit Insurance Corporation, Signature Bank, Starwood Capital Group, Carlyle Group, Blackstone, Thoma Bravo, Brookfield Asset Management, Bloomberg, FDIC, Newmark Group, Thomson Locations: Bengaluru

☆ Centrica hikes dividend as profits at British Gas soar
▼ + stars: | 2023-07-27 | by ( ) www.cnbc.com time to read: +2 min

Britain's Centrica announced bumper returns for shareholders on Thursday after its first-half profits surged on an almost ten-fold increase at its British Gas supply business. Centrica has doubled its support package for struggling customers to 100 million pounds ($130 million), it added. The British Gas Energy supply division posted adjusted profits of 969 million pounds versus 98 million a year earlier. The firm said it would invest 4 billion pounds by 2028 on security of supply, energy flexibility and renewable power. Overall, Centrica's adjusted operating profit for the first six months of 2023 rose to 2.08 billion pounds from 1.34 billion pounds a year earlier.

Persons: Britain's Centrica, Chris O'Shea, Centrica, O'Shea Organizations: British Gas, British Gas Energy, EDF's Locations: Ukraine

☆ Britain's Centrica hikes dividend as profits at British Gas soar
▼ + stars: | 2023-07-27 | by ( Susanna Twidale | ) www.reuters.com time to read: +1 min

July 27 (Reuters) - Britain's Centrica (CNA.L) proposed a 33% increase in its interim dividend on Thursday after posting a jump in first-half profits, buoyed by higher returns from its British Gas supply business. The British Gas Energy supply division posted adjusted profits of 969 million pounds ($1.25 billion) compared with 98 million the same period last year. Centrica said some 500 million pounds of this related to changes to the regulator's price cap which allowed the company to recoup previously lost costs. The company also announced plans to invest 4 billion pounds by 2028 on security of supply, energy flexibility and renewable power. Overall Centrica's adjusted operating profit for the first six months of 2023 rose to 2.08 billion pounds up from 1.34 billion pounds a year earlier.

Persons: Centrica, Susanna Twidale, Prerna Bedi, Varun, Sharon Singleton Organizations: British Gas, British Gas Energy, Thomson Locations: Britain, London, Bengaluru

☆ Binance withdraws application for crypto license in Germany
▼ + stars: | 2023-07-26 | by ( ) www.reuters.com time to read: +1 min

July 26 (Reuters) - Binance has withdrawn its application for a crypto license in Germany, suggesting the world's biggest cryptocurrency exchange is rethinking its immediate expansion plans amid a tough regulatory stance towards the industry. German regulators had told Binance they would not grant it a crypto custody license, Reuters reported last month. "Binance confirms it has proactively withdrawn its BaFin (Germany's financial regulator) application. The situation, both in the global market and regulation, has changed significantly," a spokesperson for the company said on Wednesday. "Binance still intends to apply for appropriate licensing in Germany, but it is essential that our submission accurately reflects these changes," the spokesperson added.

Persons: Binance, Changpeng Zhao, Niket, Elizabeth Howcroft, KRishna Chandra Organizations: Reuters, U.S . Securities, Exchange, CoinDesk, Thomson Locations: Germany, Netherlands, France, Bengaluru, London

☆ Don't chase the Coinbase rally as regulatory risks still linger, analysts warn
▼ + stars: | 2023-07-25 | by ( Tanaya Macheel | ) www.cnbc.com time to read: +2 min

Investors shouldn't chase the Coinbase rally that was sparked by a pop in crypto asset XRP due to a partial legal win in federal court, analysts warned. The judge also ruled that Ripple violated securities laws when selling XRP to institutions but not to retail investors. However, some analysts noted investors should stay cautious around Coinbase for a little while longer. Despite the ways Coinbase and the crypto industry can benefit from the ruling, the dark cloud of regulatory uncertainty hasn't gone away yet. He added that although the ruling is positive, it's "not a Panacea" for Coinbase.

Persons: XRP, Peter Christiansen, Bank of America's Jason Kupferberg, Kupferberg, Christiansen, Michael Bloom Organizations: of, Citi, Bank of America's, SEC, Coinbase, Bank of America, America's Locations: Southern, of New York, Cancun

☆ FTC and DOJ lay out new rules for merger review to reflect a digital economy
▼ + stars: | 2023-07-19 | by ( Lauren Feiner | ) www.cnbc.com time to read: +5 min

The Federal Trade Commission and the Department of Justice Antitrust Division announced on Wednesday new long-awaited guidelines on how they will enforce merger law. Almost two years ago, the FTC voted to withdraw the previous version of the vertical merger guidelines released in 2020, citing flaws. A vertical merger is a transaction between two businesses that are often in different parts of the supply chain in an industry, according to the FTC. Microsoft's proposed $68.7 billion purchase of Activision Blizzard is an example of a vertical merger, because Microsoft distributes games through its Xbox consoles and streaming services, while Activision creates the games. On the call with reporters, the FTC official and a senior DOJ official said the guidelines reflect their updated approach to enforcing merger law, emphasizing the law itself has not changed.

Persons: Antitrust Jonathan Kanter, Lina Khan, Microsoft's, Jonathan Kanter, they're Organizations: Antitrust, Federal Trade, American Bar Association Antitrust, Marriott Marquis, Washington , D.C, Federal Trade Commission, Department of Justice Antitrust, FTC, Activision Blizzard, Microsoft, Activision, Big Tech, DOJ, Facebook, Democratic, CNBC, YouTube Locations: Washington ,

☆ US securities regulator 'disappointed' with defeat over Ripple's XRP
▼ + stars: | 2023-07-17 | by ( ) www.reuters.com time to read: +3 min

WASHINGTON, July 17 (Reuters) - The head of the U.S. securities regulator said Monday the agency was "disappointed" with a judge's recent ruling that Ripple Labs Inc did not violate federal securities laws in a major blow to its efforts to rein in the cryptocurrency sector. The SEC has sued a number of crypto firms in recent months, arguing that most crypto tokens are securities that should be registered with the agency. AI could also amplify the world financial system's interconnectedness, something for which current risk management models may not be prepared, Gensler said. "Many of the challenges to financial stability that AI may pose in the future ... will require new thinking on system-wide or macro-prudential policy interventions." Gensler's remarks echoed statements he has made in recent months on managing risks created by the use of AI in finance.

Persons: Gary Gensler, Gensler, Gensler's, We've, It's, Douglas Gillison, Andrea Shallal, Hannah Lang, Matthew Lewis, David Evans, Nick Zieminski Organizations: Ripple Labs, U.S . Securities, Exchange, SEC, prudential, Thomson Locations: cryptocurrency, U.S, Washington

Unlike the U.S., where home buyers can snag a 30-year mortgage, Canadian borrowers must renew their mortgages every five years at the prevailing interest rates. MORTGAGE DELINQUENCIES LOWLatest data released during the quarterly earnings showed mortgage delinquencies for all banks were low. Of the big six banks in Canada, Bank of Nova Scotia (BNS.TO) and National Bank of Canada (NA.TO) do not offer mortgage extensions, meaning the payment owed by the consumer goes up for each hike the BoC announces. Bank of Montreal (BMO.TO), CIBC (CM.TO) and TD Bank (TD.TO) each allow for negative amortization as rates rise. So it is working counter to what the Bank of Canada is trying to accomplish," Briggs added.

Persons: Greg Taylor, Desjardins, Mike Rizvanovic, Rizvanovic, Darcy Briggs, Briggs, Nivedita Balu, Josie Kao, David Gregorio Our Organizations: TORONTO, Bank, Purpose Investments, Bank of Nova, National Bank of Canada, BoC, RBC, Scotiabank, National Bank, Bank of Montreal, CIBC, TD Bank, Desjardins . Royal Bank of Canada, BMO, Franklin Templeton, Bank of Canada, Thomson Locations: U.S, Canada, Bank of Nova Scotia, Franklin Templeton Canada, Toronto

CompaniesLaw Firms Ripple Labs Inc FollowCoinbase Global Inc FollowJuly 13 (Reuters) - Ripple Labs Inc did not violate federal securities law by selling its XRP token on public exchanges, a U.S. judge ruled on Thursday, a landmark legal victory for the cryptocurrency industry that sent the value of XRP soaring. An SEC spokesperson said the agency was pleased with part of the ruling in which the judge held that Ripple violated federal securities law by selling XRP directly to sophisticated investors. XRP sales on cryptocurrency platforms by Garlinghouse and co-founder and former CEO Chris Larsen, and other distributions including compensation to employees also did not involve securities, Torres ruled. PARTIAL WIN FOR THE SECThe SEC won a partial victory as Torres found the company's $728.9 million of XRP sales to hedge funds and other sophisticated buyers amounted to unregistered sales of securities. Both the Ripple and Coinbase cases focus on registration requirements and whether certain digital assets are securities under U.S. law.

Persons: XRP, Analisa Torres, Brad Garlinghouse, We’ve, Torres, Paul Grewal, Chris Larsen, Garlinghouse, Larsen, Gary DeWaal, Rosenman, Tom Emmer, Jody Godoy, Chris Prentice, Tom Hals, Chizu Nomiyama, Conor Humphries, Leslie Adler, David Gregorio Our Organizations: Labs, Ripple Labs, U.S, District, U.S . Securities, Exchange Commission, SEC, Twitter, Supreme, WIN FOR, Republican, Thomson Locations: U.S, XRP, Katten, New York, Wilmington , Delaware

Search resuls for: "regulator's"

25 mentions found